Hypermethylation of the p15INK4B gene in myelodysplastic syndromes

@inproceedings{Uchida1997HypermethylationOT,
  title={Hypermethylation of the p15INK4B gene in myelodysplastic syndromes},
  author={Toshiki Uchida and Tomohiro Kinoshita and Hirokazu Nagai and Yohsuke Nakahara and Hidehiko Saito and Tomomitsu Hotta and Takashi Murate},
  year={1997}
}
Previous studies have shown that the cyclin-dependent kinase inhibitor (CDKI) genes p15INK4B and p16INK4A are frequently inactivated by genetic alterations in many malignant tumors and that they are candidate tumor-suppressor genes. Although genetic alterations in these genes may be limited to lymphoid malignancies, it has been reported that their inactivation by aberrant methylation of 5′ CpG islands may be involved in various hematologic malignancies. In this study, we investigated the… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 87 CITATIONS, ESTIMATED 56% COVERAGE

The myelodysplastic syndrome as a prototypical epigenetic disease.

VIEW 9 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Epigenetic changes in the myelodysplastic syndrome.

  • J P Issa
  • Medicine
  • Hematology/oncology clinics of North America
  • 2010
VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

p15INK4b, a Tumor Suppressor in Acute Myeloid Leukemia

VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Azacitidine Use for Myeloid Neoplasms

CDK inhibitors for muscle stem cell differentiation and self-renewal.

FILTER CITATIONS BY YEAR

1998
2018

CITATION STATISTICS

  • 6 Highly Influenced Citations